Home › Funds › CASTLEKEEP INVESTMENT ADVISORS LLC › NVS

CASTLEKEEP INVESTMENT ADVISORS LLC position in NVS

Novartis Ag Sponsored ADR · Health Care

CASTLEKEEP INVESTMENT ADVISORS LLC reported holding 7,625 shares of NVS (Novartis Ag Sponsored ADR) in its Q3 2026 13F filing — a position valued at US$1.1M, representing 0.56% of its reported portfolio and ranking #29 among its reported holdings. CASTLEKEEP INVESTMENT ADVISORS LLC has disclosed NVS holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

Latest position (Q3 2026)7.62K sh
Reported value held$1.09M
Portfolio Weight0.56%
First reportedQ4 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How CASTLEKEEP INVESTMENT ADVISORS LLC's NVS position evolved

CASTLEKEEP INVESTMENT ADVISORS LLC first disclosed a stake in NVS in Q4 2023 at 11,148 shares (US$1.1M). The position peaked in Q2 2025 at 11,112 shares, worth US$1.3M. Across 12 filings, CASTLEKEEP INVESTMENT ADVISORS LLC increased the stake 4 time(s), trimmed it 6 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 7,625 shares valued at US$1.1M — an increase of 833 shares quarter over quarter.. Notable position changes include a 29% trim in Q3 2025 (shares rose 8% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 11.15K $1.13M New
Q1 2024 10.08K $974.94K Reduce
Q2 2024 10.05K $1.07M Hold
Q3 2024 10.51K $1.21M Add
Q4 2024 11.59K $1.13M Add
Q1 2025 11.97K $1.33M Add
Q2 2025 11.11K $1.34M Reduce
Q3 2025 7.92K $1.02M Reduce
Q4 2025 7.57K $1.04M Reduce
Q1 2026 7.29K $1.11M Reduce
Q2 2026 6.79K $1.06M Reduce
Q3 2026 7.62K $1.09M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NVS and 13F data

NVS (Novartis Ag Sponsored ADR) is a Health Care company. 20 other funds we track also report a position in NVS — the largest reported positions include Fisher Asset Management, LLC (US$2.39B), PRIMECAP MANAGEMENT CO/CA/ (US$938.9M), LOOMIS SAYLES & CO L P (US$689.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NVS

All NVS fund holders →

FAQ

How long has CASTLEKEEP INVESTMENT ADVISORS LLC held NVS?

CASTLEKEEP INVESTMENT ADVISORS LLC has disclosed NVS holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

What is CASTLEKEEP INVESTMENT ADVISORS LLC's current position in NVS?

As of Q3 2026, CASTLEKEEP INVESTMENT ADVISORS LLC holds 7.62K shares of NVS (Novartis Ag Sponsored ADR), valued at $1.09M, representing 0.56% of its reported portfolio and ranking #29.

Has CASTLEKEEP INVESTMENT ADVISORS LLC been buying or selling NVS?

In the latest 13F filing (Q3 2026), CASTLEKEEP INVESTMENT ADVISORS LLC increased its position in NVS. The position peaked in Q2 2025 at 11.11K shares.

Which other funds hold NVS?

Other major institutional holders of NVS include Fisher Asset Management, LLC, PRIMECAP MANAGEMENT CO/CA/, LOOMIS SAYLES & CO L P, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.